Biotech Investment Analyst — Drug Asset & Company Assessment

Official role reputed company reputed company is partnering with a biotech and reputed company research team on expert reputed company-evaluation work — creating and critiquing rubrics that analyze reputed company drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a reputed company reputed company, with the potential to continue as the work scales. — Responsibilities Create and critique rubrics that analyze reputed company drugs and drug-development programs reputed company overall company and asset assessment — reputed company, clinical data, competitive position, and value drivers Judge the reputed company of an investment-style reputed company and flag weak, overconfident, or missing assumptions Apply your assessment across the reputed company's set of companies (~5–10) — Requirements US-based biotech / reputed company investment analyst with a specialist-fund background Familiarity with biotech/reputed company development programs reputed company to assess a drug asset and reputed company behind it end-to-end 5+ years evaluating biotech/reputed company companies or assets — Engagement Details Duration: Approximately 10–20 hours over a 1–2 week reputed company Remote — US-based — Why Participate Help improve expert AI evaluation of drugs and drug-development programs Recurring engagement for strong contributors Relevant skills AI evaluationClinical reasoningResearch Apply tot his job Apply To this Job